The pharmaceutical market: a transdisciplinary description of concepts and their implications
Drug prices reflect the interaction of market structure, R&D investment, licensing arrangements, and patient behavior. Biopharmaceuticals entail added complexity and cost. Monopolistic or oligopolistic conditions can result in suboptimal pricing and unmet demand, highlighting the need for stronger regulatory oversight.
Authors
- Jeff Gow (ORCID: https://orcid.org/0000-0002-5726-298X)
- André Soares Motta-Santos
- Khorshed Alam (ORCID: https://orcid.org/0000-0002-6003-6991)
- Leonardo Costa Ribeiro
- Mônica Viegas Andrade
- Kenya Valéria Micaela de Souza Noronha
Institutions
- Universidade Federal de Minas Gerais (BR)
- University of Southern Queensland (AU)
Publication Details
- Journal
- Expert Review of Pharmacoeconomics & Outcomes Research
- Published
- 2026-01-06
- DOI
- https://doi.org/10.1080/14737167.2026.2613683
- Primary Topic
- Pharmaceutical Economics and Policy
- Type
- article
- Field-Weighted Citation Impact
- 0.00